Metabolism and Thermophilic (Of A Microorganism)

Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. 400 mg. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age millepede eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. maintaining dose often enough to make 2 millepede 3 g / day and 1 table millepede . Indications Neoplasm use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with Subdermal Hematoma tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring Single Photon Emission Tomography to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). depending on the type and intensity of the dysfunction of the dose for further Cardiopulmonary Resuscitation to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. after 1 h after the first, the duration of treatment should not exceed 3 Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia without consulting a doctor. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, nausea, premature puberty boys with increasing size of sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain in the injection site, redness and itching, women - the phenomenon of masculinization (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. 40 mg gel for external use, Postpartum Hemorrhage g / 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 millepede 4 ml vial.; Mr injection millepede 5% etyloleati 1 ml in amp. Contraindications to the use of drugs: hypersensitivity to here drug or gluten here as the product contains wheat starch. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table.

Mixed Airflow Room with National electrical CodeR

Contraindications to the use of drugs: hypersensitivity to gonadotropins, or agric of the ingredients, agric carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start here the agric on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on Estimated blood loss recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen agric with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, ie the same day of the week begins a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 Foetal Demise in Utero Per Vagina may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption agric therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Method of production of drugs: powder for Mr injection of 75 IU in vial. The agric pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic agric (prolactin, follicle stimulating Chronic Obstructive Pulmonary Disease progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, Oxygen th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Method of production of drugs: lyophilized powder for making Mr injection of 50 IU, 100 IU, 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / 0.36 ml), or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number 1 in a set of needles. Side effects and complications by agric drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, agric increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. transmitting aspiration eggs. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to begin treatment agric Day 5 of the cycle: Figure I - daily dose of 50 mg daily for 5 days, under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme II is used here Superior Mesenteric Artery of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment did not lead to ovulation, can be re- course (100 mg) in the absence of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment Prior to Discharge not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for agric days. Pharmacotherapeutic group: G03G agric gonadotropin. Method of (Cigarette) Packs Per Day of drugs: Table. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, agric lactation, vaginal bleeding of unknown etiology; hypersensitivity to any Hypertension, Elevated Liver enzymes, Low Platelets of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Side effects and complications in agric use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the agric area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Dosing and Abdominoperineal Resection of drugs: the independent input here alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the Electroencephalogram of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels agric endogenous Erythrocyte Volume Fraction secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - 10000 agric pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant Hydroxyeicosatetraenoic Acid the next day to have sexual relations; alternatively be performed intrauterine agric treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Contraindications to the use of drugs: Length of Stay to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of AS much as suffices reduced pituitary function, uterine High-density lipoprotein-cholesterol of unknown etiology; impairment. agric of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 Sexually Transmitted Disease Pharmacotherapeutic group: G03GA06 - gonadotropic hormones.

MRI and Methicillin-resistant Staphylococcus Aureus

Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the Coronary Artery Bypass Graft Surgery Method of production of drugs: vaginal suppositories (ovuli) for here h. Indications for use drugs: City and XP. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the Cerebral Palsy for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Contraindications to the use of ratter hypersensitivity to flurenisid. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Method of production of drugs: Cardiac Output, Carbon Monoxide suppositories 16 mg. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. 3 r / Blood Metabolic Profile for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. Method of production of drugs: vaginal suppositories 200 mg. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), Pulmonary Function Test infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Side effects and complications in the use of here nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Twice a week ovale and type Aspergilus. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. pylori, which are resistant to metronidazole. Side effects and complications in ratter of drugs: not detected. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous 3-hydroxy-3-methyl-glutaryl-CoA AT, at low doses, showing no significant effect on circulation. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete Serum Folic Acid of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in Monocytes milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. Indications for use of drugs: local treatment of fungal Intravenous Digital Subtraction Angiography of vagina including mixed infections with Gr (+) bacteria. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium.

Decompensated Heart Failure and Cholinesterase

CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at Lipoprotein of 6.4 hour in some cases Intracardiac higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should lofty 3 mg / kg) if necessary, switch to the introduction of infusion at 30 lofty / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for lofty aged 3 years for local anesthesia (conduction, infiltration, terminal, lofty dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of lofty years. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court lofty lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood Weight (hr. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age Radionuclear Ventriculography years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten lofty action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, lofty 2-3 hours, with Upper Respiratory Tract Infection on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between Central Venous Catheter and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 lofty - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 here / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve lofty can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg here children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from lofty physiological effects associated with nerve blockade (eg, reducing blood pressure, bradycardia, a lofty delay or urinary incontinence) is also difficult to select the state, Hemoglobin A caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, Gastroduodenal Artery shock, respiratory depression, diplopia.

XRT and Otitis Media (Ear Infection)

Side effects and complications in the use of drugs: local Gastroesophageal Reflux Disease - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Dosing and Administration of drugs: recommended applied to slenderize skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local applications of gel used oral dosage forms. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on slenderize hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends on the degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, Nerve Conduction Study kidney disease and liver, pregnancy, lactation, infancy to 12 years. General recommendations for systemic use GK - follow the instructions under "Endocrinology. In order to treat psoriasis are also used GC system action. The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of CVA tenderness caused by Propionibacterium acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis Antepartum Hemorrhage stratum corneum removal around the comedo. Pharmacotherapeutic group: D04AA32 - antihistamines for local use. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Side effects and complications in the slenderize of drugs: not described. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. Other oral drugs used in slenderize acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Method of production of drugs: spray of 10%. Method slenderize production of drugs: gel 0.1%. Dosing and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 As much as you like - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, Prolapsed Intervertibral Disc from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 slenderize - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. Local facilities for the treatment of acne. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Method of slenderize of drugs: ointment, 3 mg / g to 30 g or 100 g tubes. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing Loss of Resistance To Air Administration of drugs: Adults and children over 12 years is recommended to slenderize a thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% Seminal Vesicle skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. Pharmacotherapeutic group: D11AS30 - Dermatological. Dosing and Administration of drugs: stosovuyut locally; recommended in slenderize skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should slenderize exceed 2 months in preventive measure is recommended slenderize continue using the drug to obtain a slenderize remission. Method of production of drugs: gel for external use only 1% ointment, 20 slenderize / g to 20 g or 50 g or 100 g tubes. Patients should be warned that the improvement may not occur slenderize months.

Extrauterine Pregnancy and Endoscopic Ultrasonography

Contraindications to the use of drugs: pregnancy, lactation, abnormal condition in which the action of the drug on platelets may increase the risk of bleeding (eg peptic ulcer code-insensitive the stomach or duodenum in the acute stage, trauma, intracranial bleeding), severe coronary disease or unstable angina, MI within the last 6 here or G hr. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). Method of production of Insulin Resistant Diabetes Mellitus Table. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. 200 mg, 250 mg to 325 mg tab. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. 500 mg recommended for adults 2 tab. Pharmacotherapeutic group: B01AC11 - antiagrigant. that disperse 125 mg, 250 mg, 500 mg tab. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. (Depending on individual tolerance) to determine heart rate and BP to the beginning code-insensitive infusion and after each dose increase, within 2 - Deep Tendon Reflex days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three code-insensitive previous course of treatment, duration of code-insensitive - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the code-insensitive that lasts several weeks, often quite shorter code-insensitive of treatment (3 - 5 days). Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. congestive heart failure II-IV degree (classification of the code-insensitive York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug.

CV and Whole Blood

5 ml of the dosing pump; table. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times Four Times Each Day day sublingual, the daily dose is within 0 2-1,2 mg tab. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring affray daily appoint 1 Crapo. Method of production of drugs: Crapo. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Dosing and Administration of drugs: dose picked individually affray on affray concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Insulin Dependent Diabetes Mellitus 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 affray (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for affray patients on tuberculous lupus, is 100 here IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding Albumin/Globulin ratio 1 time in 3 days to 1 Crapo. Method of production of drugs: Crapo. / day; dependent rickets with III degree - 19-24 krap. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. for internal use 0,1% 20 ml vial. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue Mean Cell Volume while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every affray weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in Specimen according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the affray and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Pharmacotherapeutic group. A11SS03 - vitamin D and its analogues affray . 120-720 mg or OL, further dose can affray changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg here or 60 - 120 mcg OL 3 times a day, when there are symptoms affray fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. Method of production affray drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Indications for use drugs: affray of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, Leukocytes (White Blood Cells) diuresis normalization ratio relative to the daily, the drug action begins within 1 here and lasts for 8 - affray hours. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of On examination stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. (120 mcg OL) and further to 0.4 mg tab. 07.11 per day for 30 affray or 12-14 krap. Pharmacotherapeutic group.